Global Baloxavir Marboxil API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR082501393

Publication Date:

August 4, 2025

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Baloxavir Marboxil API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Baloxavir Marboxil API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Baloxavir Marboxil API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Baloxavir Marboxil API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Baloxavir Marboxil API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Baloxavir Marboxil API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Baloxavir Marboxil API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Baloxavir Marboxil API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hangzhou Longshine Bio-Tech, Huateng Pharma, Changzhou Pharmaceutical Factory, Metrochem API, Teva API, Bulat Pharmaceutical, Hetero Drugs, MSN Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Baloxavir Marboxil API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.98
0.99
Others
Market segment by Application
Medical Pharmaceutical
Scientific Research
Major players covered
Hangzhou Longshine Bio-Tech
Huateng Pharma
Changzhou Pharmaceutical Factory
Metrochem API
Teva API
Bulat Pharmaceutical
Hetero Drugs
MSN Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Baloxavir Marboxil API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Baloxavir Marboxil API, with price, sales quantity, revenue, and global market share of Baloxavir Marboxil API from 2020 to 2025.
Chapter 3, the Baloxavir Marboxil API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Baloxavir Marboxil API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Baloxavir Marboxil API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Baloxavir Marboxil API.
Chapter 14 and 15, to describe Baloxavir Marboxil API sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Baloxavir Marboxil API Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 0.98
1.3.3 0.99
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Baloxavir Marboxil API Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical Pharmaceutical
1.4.3 Scientific Research
1.5 Global Baloxavir Marboxil API Market Size & Forecast
1.5.1 Global Baloxavir Marboxil API Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Baloxavir Marboxil API Sales Quantity (2020-2031)
1.5.3 Global Baloxavir Marboxil API Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Hangzhou Longshine Bio-Tech
2.1.1 Hangzhou Longshine Bio-Tech Details
2.1.2 Hangzhou Longshine Bio-Tech Major Business
2.1.3 Hangzhou Longshine Bio-Tech Baloxavir Marboxil API Product and Services
2.1.4 Hangzhou Longshine Bio-Tech Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
2.2 Huateng Pharma
2.2.1 Huateng Pharma Details
2.2.2 Huateng Pharma Major Business
2.2.3 Huateng Pharma Baloxavir Marboxil API Product and Services
2.2.4 Huateng Pharma Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Huateng Pharma Recent Developments/Updates
2.3 Changzhou Pharmaceutical Factory
2.3.1 Changzhou Pharmaceutical Factory Details
2.3.2 Changzhou Pharmaceutical Factory Major Business
2.3.3 Changzhou Pharmaceutical Factory Baloxavir Marboxil API Product and Services
2.3.4 Changzhou Pharmaceutical Factory Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
2.4 Metrochem API
2.4.1 Metrochem API Details
2.4.2 Metrochem API Major Business
2.4.3 Metrochem API Baloxavir Marboxil API Product and Services
2.4.4 Metrochem API Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Metrochem API Recent Developments/Updates
2.5 Teva API
2.5.1 Teva API Details
2.5.2 Teva API Major Business
2.5.3 Teva API Baloxavir Marboxil API Product and Services
2.5.4 Teva API Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Teva API Recent Developments/Updates
2.6 Bulat Pharmaceutical
2.6.1 Bulat Pharmaceutical Details
2.6.2 Bulat Pharmaceutical Major Business
2.6.3 Bulat Pharmaceutical Baloxavir Marboxil API Product and Services
2.6.4 Bulat Pharmaceutical Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bulat Pharmaceutical Recent Developments/Updates
2.7 Hetero Drugs
2.7.1 Hetero Drugs Details
2.7.2 Hetero Drugs Major Business
2.7.3 Hetero Drugs Baloxavir Marboxil API Product and Services
2.7.4 Hetero Drugs Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Hetero Drugs Recent Developments/Updates
2.8 MSN Laboratories
2.8.1 MSN Laboratories Details
2.8.2 MSN Laboratories Major Business
2.8.3 MSN Laboratories Baloxavir Marboxil API Product and Services
2.8.4 MSN Laboratories Baloxavir Marboxil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 MSN Laboratories Recent Developments/Updates
3 Competitive Environment: Baloxavir Marboxil API by Manufacturer
3.1 Global Baloxavir Marboxil API Sales Quantity by Manufacturer (2020-2025)
3.2 Global Baloxavir Marboxil API Revenue by Manufacturer (2020-2025)
3.3 Global Baloxavir Marboxil API Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Baloxavir Marboxil API by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Baloxavir Marboxil API Manufacturer Market Share in 2024
3.4.3 Top 6 Baloxavir Marboxil API Manufacturer Market Share in 2024
3.5 Baloxavir Marboxil API Market: Overall Company Footprint Analysis
3.5.1 Baloxavir Marboxil API Market: Region Footprint
3.5.2 Baloxavir Marboxil API Market: Company Product Type Footprint
3.5.3 Baloxavir Marboxil API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Baloxavir Marboxil API Market Size by Region
4.1.1 Global Baloxavir Marboxil API Sales Quantity by Region (2020-2031)
4.1.2 Global Baloxavir Marboxil API Consumption Value by Region (2020-2031)
4.1.3 Global Baloxavir Marboxil API Average Price by Region (2020-2031)
4.2 North America Baloxavir Marboxil API Consumption Value (2020-2031)
4.3 Europe Baloxavir Marboxil API Consumption Value (2020-2031)
4.4 Asia-Pacific Baloxavir Marboxil API Consumption Value (2020-2031)
4.5 South America Baloxavir Marboxil API Consumption Value (2020-2031)
4.6 Middle East & Africa Baloxavir Marboxil API Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
5.2 Global Baloxavir Marboxil API Consumption Value by Type (2020-2031)
5.3 Global Baloxavir Marboxil API Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
6.2 Global Baloxavir Marboxil API Consumption Value by Application (2020-2031)
6.3 Global Baloxavir Marboxil API Average Price by Application (2020-2031)
7 North America
7.1 North America Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
7.2 North America Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
7.3 North America Baloxavir Marboxil API Market Size by Country
7.3.1 North America Baloxavir Marboxil API Sales Quantity by Country (2020-2031)
7.3.2 North America Baloxavir Marboxil API Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
8.2 Europe Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
8.3 Europe Baloxavir Marboxil API Market Size by Country
8.3.1 Europe Baloxavir Marboxil API Sales Quantity by Country (2020-2031)
8.3.2 Europe Baloxavir Marboxil API Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Baloxavir Marboxil API Market Size by Region
9.3.1 Asia-Pacific Baloxavir Marboxil API Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Baloxavir Marboxil API Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
10.2 South America Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
10.3 South America Baloxavir Marboxil API Market Size by Country
10.3.1 South America Baloxavir Marboxil API Sales Quantity by Country (2020-2031)
10.3.2 South America Baloxavir Marboxil API Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Baloxavir Marboxil API Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Baloxavir Marboxil API Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Baloxavir Marboxil API Market Size by Country
11.3.1 Middle East & Africa Baloxavir Marboxil API Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Baloxavir Marboxil API Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Baloxavir Marboxil API Market Drivers
12.2 Baloxavir Marboxil API Market Restraints
12.3 Baloxavir Marboxil API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Baloxavir Marboxil API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Baloxavir Marboxil API
13.3 Baloxavir Marboxil API Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Baloxavir Marboxil API Typical Distributors
14.3 Baloxavir Marboxil API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Hangzhou Longshine Bio-Tech
Huateng Pharma
Changzhou Pharmaceutical Factory
Metrochem API
Teva API
Bulat Pharmaceutical
Hetero Drugs
MSN Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂